Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 37 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9567387

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  2. US 9566329

    Live, attenuated rubella vector to express vaccine antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  3. US 9562237

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  4. US 9556237

    Antiviral rift valley fever virus peptides and methods of use

    The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  5. US 9556244

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  6. US 9549975

    Genetically engineered swine influenza virus and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  7. US 9550818

    Methods for use of vascular endothelial growth factor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  8. US 9550742

    11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  9. US 9545431

    Isolated recombinant cDNA

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  10. US 9540427

    Peptide-based stat inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  11. US 9540415

    Inhibitors of the farnesoid X receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  12. US 9540642

    Compositions and methods for controlling arthropod parasite and pest infestations

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  13. US 9540471

    Nitric oxide-releasing diazeniumdiolated polyvinylpyrrolidone-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  14. US 9539220

    Methods for treating suicidal ideation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  15. US 9534008

    Small molecule compounds that control plant- and insect-pathogenic nematodes

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  16. US 9534041

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  17. US 9532989

    Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  18. US 9526777

    Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  19. US 9526739

    Compositions and methods to treat cardiac diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  20. US 9528094

    Attenuated African swine fever virus vaccine based in the deletion of MGF genes

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  21. US 9527903

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  22. US 9522948

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  23. US 9522955

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  24. US 9522871

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.